EGFR and Skin rash: A number of studies have suggested that from a clinical point of view, the severity of skin rash is positively correlated with clinical outcome (response rates, progression free survival and OS) and, thus, it could be used in order to distinguish mCRC patients more likely to be sensitive to anti-EGFR treatment [2], [32], [42].